| | | The first patient with lung cancer to be treated with a type of immunotherapy involving the re-engineering of a patient's T cells, known as TCR T-cell therapy, took place at Winship on May 7. The patient is enrolled on a clinical trial evaluating the safety and tolerability of a TCR T-cell therapy product in patients with lung cancer. Pictured: Edmund K. Waller, MD, PhD, Taofeek K. Owonikoko, MD, PhD, Hallie Marino, BSN, RN, BMTCN, and Tolu Adewuya, MMedSci, PhD, CCRC with the patient. | Read More |
| |
| | Emory announces Nursing Excellence Award winners | Twenty-two nurses, including eleven who support Winship Cancer Institute patients, have been selected as the winners of this year’s Emory Healthcare Nursing Excellence Awards. Nominated by their peers, the award recipients were announced by the Emory Healthcare Nursing Recruitment and Retention Council during National Nurses Week, May 6-12.
| Read More | |
| | | | New Edge enhances stereotactic radiosurgery at Winship | A new Edge radiosurgery system is being installed on Winship's Clifton campus that will enhance the Department of Radiation Oncology's large stereotactic radiosurgery program. The Edge is used in a variety of medical diagnoses to deliver stereotactic radiosurgery and radiotherapy treatments with a high degree of precision and accuracy.
| Read More | |
|
| |
| | Winship holds virtual Town Hall | Executive Director Walter J. Curran, Jr., MD and members of Winship's senior leadership team shared updates and answered questions during a virtual Town Hall on May 6. Log in to the Winship intranet to view a recording of the event.
| Visit Winship Intranet | |
| | | |
| |
| | Anti-PD-1 agent evaluated for merkel cell carcinoma | Ragini Kudchadkar, MD and collaborators from the Checkmate 358 trial evaluated the use of nivolumab, an anti-PD-1 antibody, in patients with resectable merkel cell carcinoma. The results of the phase I/II study were published April 23 in the Journal of Clinical Oncology.
| Read More | |
| | | |
| |
| | Gichoya awarded CECI² membership | Judy Gichoya, MD, MS has been named to the Council of Early Career Investigators in Imaging (CECI²) by the Academy for Radiology & Biomedical Imaging Research. Membership in CECI² recognizes high achieving researchers and provides opportunities to attend an annual showcase and advocacy efforts in Washington, D.C.
| About CECI² | |
| | | | Lewis named to ASPHO Education Committee | Colleen Lewis, MSN, ANP-BC, AOCNP has been named to the Education Committee of the Advanced Practitioner Society for Hematology and Oncology (ASPHO). The society comprises nurse practitioners, physician assistants, clinical nurse specialists, advanced degree nurses, and pharmacists.
| About ASPHO | |
|
| |
| | Vu receives scholar award and visionary grant | Ha Ngan "Milkie" Vu, a PhD student whose dissertation committee includes Drs. Cam Escoffery and Bob Bednarczyk, has received a P.E.O. Scholar Award as well as a 2019 Visionary Grant from the American Psychological Foundation.
| Read More | |
| | | |
| |
| |
| Emory's official 175th Commencement ceremony on May 11 will draw upon university traditions and new technological innovations to celebrate the outstanding achievements of this year’s graduates. | Read More |
| |
| | May 14 - No Surgical Grand Rounds |
| |
| | May 15 - No Elkin Lecture |
| |
| |
| A selection of media stories and news coverage for Winship Cancer Institute. |
| |
| You are receiving Winship Roundup as a member or employee of Winship Cancer Institute. If you wish to unsubscribe, please email Winship Communications.
Emory Home |
Emory News Center |
Give to Emory |
Contact Emory Have a story for Winship Roundup? Submit your suggestion via email. © 2021 Winship Cancer Institute of Emory University |
1365 Clifton Rd. NE, Bldg. C, Atlanta, Georgia 30322 | |
|